30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ascendis Pharma A/S (ASND)

Over the last 90 days, Ascendis Pharma A/S has seen significant insider selling, with a net value of -$4.36 million. Total sales amounted to $9.28 million, while purchases were only $0.28 million. This trend is primarily driven by large sell transactions from executives, despite some recent smaller buy transactions.
Stock chart
Ticker: ASND Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SMITH SCOTT THOMAS
EVP & Chief Financial Officer
1 purchase — total 100,000 USD
Buy 2 Jun 2026
Value US$3,335,472.75 | Price 54.63 | Shares 46,097
Buy 29 May 2026
Value US$3,670,388.43 | Price 274.21 | Shares 22,823
Buy 29 May 2026
Value US$22,350.00 | Price 223.50 | Shares 100
Buy 29 May 2026
Value US$44,460.00 | Price 222.30 | Shares 200
Buy 29 May 2026
Value US$44,752.00 | Price 223.76 | Shares 200
Buy 26 May 2026
Value US$47,873.50 | Price 239.37 | Shares 200
Buy 26 May 2026
Value US$47,247.00 | Price 236.24 | Shares 200
Sale 11 May 2026
Value US$4,641,021.24 | Price 238.49 | Shares 19,460
Proposed sale 11 May 2026
Value US$4,641,021.92 | Price 238.49 | Shares 19,460
Proposed sale 9 Mar 2026
Value US$907,680.00 | Price 240.00 | Shares 3,782
Proposed sale 6 Mar 2026
Value US$2,375,307.91 | Price 237.53 | Shares 10,000
Proposed sale 5 Mar 2026
Value US$2,400,000.00 | Price 240.00 | Shares 10,000
Proposed sale 5 Mar 2026
Value US$2,400,000.00 | Price 240.00 | Shares 10,000
Proposed sale 5 Mar 2026
Value US$1,316,554.92 | Price 235.81 | Shares 5,583
Proposed sale 5 Mar 2026
Value US$22,689,720.00 | Price 241.38 | Shares 94,000
Proposed sale 4 Mar 2026
Value US$2,388,194.94 | Price 236.34 | Shares 10,105
Proposed sale 4 Mar 2026
Value US$1,743,913.80 | Price 239.22 | Shares 7,290
Proposed sale 2 Mar 2026
Value US$435,762.00 | Price 242.09 | Shares 1,800
Proposed sale 2 Mar 2026
Value US$435,762.00 | Price 242.09 | Shares 1,800
Proposed sale 2 Mar 2026
Value US$4,442,109.00 | Price 242.09 | Shares 18,349
Proposed sale 2 Mar 2026
Value US$4,442,109.00 | Price 242.09 | Shares 18,349
Proposed sale 2 Mar 2026
Value US$1,663,642.00 | Price 242.09 | Shares 6,872
Proposed sale 2 Mar 2026
Value US$2,614,572.00 | Price 242.09 | Shares 10,800
Proposed sale 2 Mar 2026
Value US$508,389.00 | Price 242.09 | Shares 2,100
Proposed sale 2 Mar 2026
Value US$508,389.00 | Price 242.09 | Shares 2,100
Proposed sale 2 Mar 2026
Value US$2,614,572.00 | Price 242.09 | Shares 10,800
Proposed sale 2 Mar 2026
Value US$2,614,572.00 | Price 242.09 | Shares 10,800
Proposed sale 2 Mar 2026
Value US$508,389.00 | Price 242.09 | Shares 2,100
Proposed sale 13 Jan 2026
Value US$18,413,630.85 | Price 211.99 | Shares 86,860
Proposed sale 4 Dec 2025
Value US$2,081,018.69 | Price 208.10 | Shares 10,000
Proposed sale 2 Dec 2025
Value US$21,085,000.00 | Price 210.85 | Shares 100,000
Proposed sale 2 Dec 2025
Value US$2,093,222.47 | Price 209.32 | Shares 10,000
Proposed sale 2 Dec 2025
Value US$2,058,454.18 | Price 205.85 | Shares 10,000
Proposed sale 1 Dec 2025
Value US$45,679.72 | Price 209.54 | Shares 218
Proposed sale 9 Sep 2025
Value US$1,018,503.05 | Price 203.70 | Shares 5,000
Proposed sale 29 Aug 2025
Value US$965,000.00 | Price 193.00 | Shares 5,000
Proposed sale 27 Aug 2025
Value US$588,814.29 | Price 193.94 | Shares 3,036
Proposed sale 20 Aug 2025
Value US$578,385.00 | Price 192.80 | Shares 3,000
Proposed sale 15 Aug 2025
Value US$1,826,403.05 | Price 194.82 | Shares 9,375
Proposed sale 14 Aug 2025
Value US$4,789,998.27 | Price 191.60 | Shares 25,000
Proposed sale 13 Aug 2025
Value US$412,319.34 | Price 191.07 | Shares 2,158
Proposed sale 13 Aug 2025
Value US$1,913,224.99 | Price 191.32 | Shares 10,000
Proposed sale 12 Aug 2025
Value US$1,925,734.17 | Price 192.57 | Shares 10,000
Proposed sale 12 May 2025
Value US$312,383.57 | Price 154.80 | Shares 2,018
Proposed sale 7 May 2025
Value US$1,774,164.03 | Price 162.20 | Shares 10,938
Proposed sale 6 May 2025
Value US$700,412.45 | Price 166.61 | Shares 4,204
Proposed sale 6 May 2025
Value US$1,700,485.02 | Price 170.05 | Shares 10,000
Proposed sale 5 May 2025
Value US$749,948.24 | Price 170.99 | Shares 4,386
Proposed sale 7 Mar 2025
Value US$585,845.92 | Price 146.46 | Shares 4,000
Proposed sale 6 Mar 2025
Value US$1,523,933.03 | Price 152.39 | Shares 10,000
Proposed sale 6 Mar 2025
Value US$245,735.01 | Price 152.25 | Shares 1,614
Proposed sale 5 Mar 2025
Value US$1,208,291.65 | Price 155.13 | Shares 7,789
Proposed sale 5 Mar 2025
Value US$349,403.00 | Price 155.01 | Shares 2,254
Proposed sale 4 Mar 2025
Value US$338,020.64 | Price 152.12 | Shares 2,222
Proposed sale 4 Mar 2025
Value US$430,208.09 | Price 152.12 | Shares 2,828
Proposed sale 4 Mar 2025
Value US$153,037.25 | Price 152.12 | Shares 1,006
Proposed sale 4 Mar 2025
Value US$153,037.25 | Price 152.12 | Shares 1,006
Proposed sale 4 Mar 2025
Value US$223,623.00 | Price 152.12 | Shares 1,470
Proposed sale 4 Mar 2025
Value US$223,623.00 | Price 152.12 | Shares 1,470
Proposed sale 4 Mar 2025
Value US$223,623.00 | Price 152.12 | Shares 1,470
Proposed sale 4 Mar 2025
Value US$2,029,949.33 | Price 152.12 | Shares 13,344
Proposed sale 4 Mar 2025
Value US$2,029,949.33 | Price 152.12 | Shares 13,344
Proposed sale 4 Mar 2025
Value US$2,029,949.33 | Price 152.12 | Shares 13,344
Proposed sale 4 Mar 2025
Value US$1,174,249.02 | Price 152.12 | Shares 7,719
Proposed sale 4 Mar 2025
Value US$1,174,249.02 | Price 152.12 | Shares 7,719
Proposed sale 4 Mar 2025
Value US$1,174,249.02 | Price 152.12 | Shares 7,719
Proposed sale 3 Mar 2025
Value US$1,210,089.33 | Price 155.14 | Shares 7,800
Proposed sale 20 Feb 2025
Value US$423,541.50 | Price 155.20 | Shares 2,729
Proposed sale 20 Feb 2025
Value US$1,542,671.14 | Price 154.27 | Shares 10,000
Proposed sale 19 Feb 2025
Value US$6,012,749.77 | Price 152.70 | Shares 39,375
Proposed sale 19 Feb 2025
Value US$756,607.17 | Price 151.32 | Shares 5,000
Proposed sale 18 Feb 2025
Value US$1,467,976.91 | Price 146.80 | Shares 10,000
Proposed sale 10 Dec 2024
Value US$273,620.96 | Price 129.13 | Shares 2,119
Proposed sale 10 Dec 2024
Value US$273,620.96 | Price 129.13 | Shares 2,119
Proposed sale 10 Dec 2024
Value US$157,793.68 | Price 129.13 | Shares 1,222
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-02 2026-06-02 B Purchase

EVP & Chief Financial Officer

Officer
46,097 -2.6%
54.63
US$3,335,473
46,097 -2.6% 54.63 US$3,335,473
2026-06-01 2026-05-29 B Purchase

EVP & Chief Financial Officer

Officer
22,823 +12.1%
274.21
US$3,670,388
22,823 +12.1% 274.21 US$3,670,388
2026-06-01 2026-05-29 B Purchase Non-Executive Director
20,343 -39.7%
50.72
US$1,474,152
20,343 -39.7% 50.72 US$1,474,152
2026-06-01 2026-05-29 B Purchase Non-Executive Director
200 +33.3%
222.30
US$44,460
200 +33.3% 222.30 US$44,460
2026-06-01 2026-05-29 B Purchase Non-Executive Director
200 +50.0%
223.76
US$44,752
200 +50.0% 223.76 US$44,752
2026-05-27 2026-05-26 B Purchase Non-Executive Director
200 +100.0%
239.37
US$47,874
200 +100.0% 239.37 US$47,874
2026-05-27 2026-05-26 B Purchase Non-Executive Director
200 +inf%
236.24
US$47,247
200 +inf% 236.24 US$47,247
2026-05-12 2026-05-11 S Sale

See Remarks

Officer
19,460 -100.0%
238.49
US$4,641,021
19,460 -100.0% 238.49 US$4,641,021
2026-05-11 2026-05-11 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
19,460
238.49
US$4,641,022
19,460 238.49 US$4,641,022
2026-03-09 2026-03-09 PrS Proposed sale

Officer

Officer
3,782
240.00
US$907,680
3,782 240.00 US$907,680
2026-03-06 2026-03-06 PrS Proposed sale

Officer

Officer
10,000
237.53
US$2,375,308
10,000 237.53 US$2,375,308
2026-03-06 2026-03-05 PrS Proposed sale

Officer

Officer
10,000
240.00
US$2,400,000
10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
5,583
235.81
US$1,316,555
5,583 235.81 US$1,316,555
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
10,000
240.00
US$2,400,000
10,000 240.00 US$2,400,000
2026-03-05 2026-03-05 PrS Proposed sale

CEO; Officer

Officer
94,000
241.38
US$22,689,720
94,000 241.38 US$22,689,720
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
10,105
236.34
US$2,388,195
10,105 236.34 US$2,388,195
2026-03-04 2026-03-04 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
7,290
239.22
US$1,743,914
7,290 239.22 US$1,743,914
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
1,800
242.09
US$435,762
1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
1,800
242.09
US$435,762
1,800 242.09 US$435,762
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
18,349
242.09
US$4,442,109
18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTUVE VP CHIEF LEGAL OFFICER

Officer
18,349
242.09
US$4,442,109
18,349 242.09 US$4,442,109
2026-03-02 2026-03-02 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
6,872
242.09
US$1,663,642
6,872 242.09 US$1,663,642
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PROD DEVELOPMENT

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
10,800
242.09
US$2,614,572
10,800 242.09 US$2,614,572
2026-03-02 2026-03-02 PrS Proposed sale

Director

Non-Executive Director
2,100
242.09
US$508,389
2,100 242.09 US$508,389
2026-01-13 2026-01-13 PrS Proposed sale

Officer; PRESIDENT CEO

Officer
86,860
211.99
US$18,413,631
86,860 211.99 US$18,413,631
2025-12-04 2025-12-04 PrS Proposed sale

Officer

Officer
10,000
208.10
US$2,081,019
10,000 208.10 US$2,081,019
2025-12-02 2025-12-02 PrS Proposed sale

CEO; Officer

Officer
100,000
210.85
US$21,085,000
100,000 210.85 US$21,085,000
2025-12-02 2025-12-02 PrS Proposed sale

Officer

Officer
10,000
209.32
US$2,093,222
10,000 209.32 US$2,093,222
2025-12-02 2025-12-02 PrS Proposed sale

Officer

Officer
10,000
205.85
US$2,058,454
10,000 205.85 US$2,058,454
2025-12-01 2025-12-01 PrS Proposed sale

Officer

Officer
218
209.54
US$45,680
218 209.54 US$45,680
2025-09-09 2025-09-09 PrS Proposed sale

Officer

Officer
5,000
203.70
US$1,018,503
5,000 203.70 US$1,018,503
2025-08-29 2025-08-29 PrS Proposed sale

Officer

Officer
5,000
193.00
US$965,000
5,000 193.00 US$965,000
2025-08-27 2025-08-27 PrS Proposed sale

Officer

Officer
3,036
193.94
US$588,814
3,036 193.94 US$588,814
2025-08-20 2025-08-20 PrS Proposed sale

President and Chief Executive Officer

Officer
3,000
192.80
US$578,385
3,000 192.80 US$578,385
2025-08-15 2025-08-15 PrS Proposed sale

Officer

Officer
9,375
194.82
US$1,826,403
9,375 194.82 US$1,826,403
2025-08-14 2025-08-14 PrS Proposed sale

Officer

Officer
25,000
191.60
US$4,789,998
25,000 191.60 US$4,789,998
2025-08-13 2025-08-13 PrS Proposed sale

Director; Non-Executive Director

Non-Executive Director
2,158
191.07
US$412,319
2,158 191.07 US$412,319
2025-08-13 2025-08-13 PrS Proposed sale

Officer

Officer
10,000
191.32
US$1,913,225
10,000 191.32 US$1,913,225
2025-08-12 2025-08-12 PrS Proposed sale

Officer

Officer
10,000
192.57
US$1,925,734
10,000 192.57 US$1,925,734
2025-05-12 2025-05-12 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
2,018
154.80
US$312,384
2,018 154.80 US$312,384
2025-05-07 2025-05-07 PrS Proposed sale

Officer

Officer
10,938
162.20
US$1,774,164
10,938 162.20 US$1,774,164
2025-05-07 2025-05-06 PrS Proposed sale

Officer; EXECUTIVE VICE PRESIDENT CHIEF MEDICAL OFFICER

Officer
4,204
166.61
US$700,412
4,204 166.61 US$700,412
2025-05-06 2025-05-06 PrS Proposed sale

Officer

Officer
10,000
170.05
US$1,700,485
10,000 170.05 US$1,700,485
2025-05-05 2025-05-05 PrS Proposed sale

Officer

Officer
4,386
170.99
US$749,948
4,386 170.99 US$749,948
2025-03-07 2025-03-07 PrS Proposed sale

Officer

Officer
4,000
146.46
US$585,846
4,000 146.46 US$585,846
2025-03-06 2025-03-06 PrS Proposed sale

Officer

Officer
10,000
152.39
US$1,523,933
10,000 152.39 US$1,523,933
2025-03-06 2025-03-06 PrS Proposed sale

Officer

Officer
1,614
152.25
US$245,735
1,614 152.25 US$245,735
2025-03-05 2025-03-05 PrS Proposed sale

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,789
155.13
US$1,208,292
7,789 155.13 US$1,208,292
2025-03-05 2025-03-05 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,254
155.01
US$349,403
2,254 155.01 US$349,403
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP AND CHIEF COMMERCIAL OFFICER

Officer
2,222
152.12
US$338,021
2,222 152.12 US$338,021
2025-03-04 2025-03-04 PrS Proposed sale

Officer; SENIOR VP PRINCIPAL ACCOUNTING OFFICER

Officer
2,828
152.12
US$430,208
2,828 152.12 US$430,208
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,006
152.12
US$153,037
1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,006
152.12
US$153,037
1,006 152.12 US$153,037
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Director

Non-Executive Director
1,470
152.12
US$223,623
1,470 152.12 US$223,623
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF CLINICAL DEV ONCOLOGY

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF FINANCIAL OFFICER

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF LEGAL OFFICER

Officer
13,344
152.12
US$2,029,949
13,344 152.12 US$2,029,949
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF RESEARCH AND PRODUCT DEV

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-04 2025-03-04 PrS Proposed sale

Officer; EXECUTIVE VP HEAD OF PRODUCT SUPPLY AND QUALITY

Officer
7,719
152.12
US$1,174,249
7,719 152.12 US$1,174,249
2025-03-03 2025-03-03 PrS Proposed sale

Officer; PRESIDENT CHIEF EXECUTIVE OFFICER

Officer
7,800
155.14
US$1,210,089
7,800 155.14 US$1,210,089
2025-02-21 2025-02-20 PrS Proposed sale

Officer; EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY

Officer
2,729
155.20
US$423,542
2,729 155.20 US$423,542
2025-02-20 2025-02-20 PrS Proposed sale

Officer

Officer
10,000
154.27
US$1,542,671
10,000 154.27 US$1,542,671
2025-02-19 2025-02-19 PrS Proposed sale

Officer

Officer
39,375
152.70
US$6,012,750
39,375 152.70 US$6,012,750
2025-02-19 2025-02-19 PrS Proposed sale

Officer

Officer
5,000
151.32
US$756,607
5,000 151.32 US$756,607
2025-02-18 2025-02-18 PrS Proposed sale

Officer

Officer
10,000
146.80
US$1,467,977
10,000 146.80 US$1,467,977
2024-12-10 2024-12-10 PrS Proposed sale

Officer; Executive Vice President, Head of Clinical Develop

Officer
2,119
129.13
US$273,621
2,119 129.13 US$273,621
2024-12-10 2024-12-10 PrS Proposed sale

Officer; Executive Vice President, Chief Legal Officer

Officer
2,119
129.13
US$273,621
2,119 129.13 US$273,621
2024-12-10 2024-12-10 PrS Proposed sale

Officer; EXECUTIVE VP CHIEF ADMINISTRATIVE OFFICER

Officer
1,222
129.13
US$157,794
1,222 129.13 US$157,794